Audrey Kunin, Chief Product Officer at NovaBay Pharmaceuticals, Inc. (NBY), sold 291,368 shares at $0.16 ($47K) on 2022-09-14, disclosed to the SEC on 2022-09-16.
Open-market sale of $47k NBY by Chief Product Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBY | BUY | 2021-12-07 | $47K | — | Filing → |
| NBY | BUY | 2021-12-06 | $252K | — | Filing → |
| NBY | BUY | 2021-12-03 | $7K | — | Filing → |